Strategic Partnerships ArteraAI has established strategic partnerships with reputable organizations like Movember Foundation, CorePlus Federal Credit Union, Inc., and GenesisCare group. Leveraging these relationships can open doors for collaboration and sales opportunities within the healthcare industry.
Innovative Technology Stack With a tech stack including GitHub, Kubernetes, Cloudflare, and others, ArteraAI showcases a commitment to innovative technological solutions. Highlighting the advanced AI capabilities to personalize treatments can attract tech-savvy healthcare institutions seeking cutting-edge solutions.
Funding and Growth Securing $20M in funding and with a revenue ranging between $10M - $50M, ArteraAI demonstrates financial stability and growth potential. This financial health positions the company as a reliable partner for long-term collaborations and investment in predictive cancer solutions.
Diverse Market Validation ArteraAI's involvement in diverse research validations, such as with the Hispanic population, underlines its commitment to inclusivity and effectiveness across demographics. This broad market validation can be leveraged to showcase the versatility and accuracy of its predictive cancer tests to a wider range of healthcare providers.
Patient-Centric Solutions The launch of chatbot-style assistants and virtual AI-powered assistants by ArteraAI demonstrates a patient-centric approach to healthcare communication. Pitching these solutions as tools to enhance patient engagement and streamline healthcare provider workflows can resonate well with organizations aiming to improve patient care experiences.
365
$50M$100M
201$50M$100M
156$10M$50M
170$10M$50M
201$50M$100M
118$10M$50M
314$50M$100M
51$10M$50MArteraAI uses 8 technology products and services including GitHub, Kubernetes, Cloudflare, and more. Explore ArteraAI's tech stack below.
| ArteraAI Email Formats | Percentage |
| First@artera.ai | 40% |
| First.Last@artera.ai | 18% |
| FLast@artera.ai | 2% |
| First@artera.ai | 40% |
Hospitals and Health CareCalifornia, United States51-200 Employees
Our AI can prognosticate patient outcomes & personalize treatment in localized prostate cancer. Five Phase III randomized trials were used to develop prognostic and predictive AI biomarkers.
Company Overview
Funding & FinancialsArteraAI has raised a total of $20M of funding over 2 rounds. Their latest funding round was raised on Feb 01, 2024 in the amount of $20M.
ArteraAI's revenue is in the range of $10M$50M
Funding & FinancialsArteraAI has raised a total of $20M of funding over 2 rounds. Their latest funding round was raised on Feb 01, 2024 in the amount of $20M.
ArteraAI's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com